Acute gastroenteritis commonly causes diarrhea and vomiting in children and adolescents, resulting in many outpatient clinic visits, emergency department visits and hospitalizations, often owing ...

Although current practice guidelines do not recommend the use of antiemetic medicines (largely owing to fear of adverse events), many clinicians do prescribe them for children with vomiting from AGE.

Dr. Deepal Perera, a paediatrician at the Lady Ridgeway Hospital for Children, states that a recent rise in fever cases among ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

PARIS, France and TARRYTOWN, NY, USA I 6, 2024 I The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis ...

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...

Spokane County is in the midst of an outbreak of whooping cough, with nearly twice the infections locally so far than the ...

The American Heart Association and the American Academy of Pediatrics update recommendations for untrained lay rescuers and trained rescuers resuscitating adults and children who have ... monitoring ...

The European Medicines Agency (EMA) approved Sanofi/Regeneron’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) ...